Plasma journey

FROM DONOR TO PATIENT

Plasma derived therapies

Immunoglobulin (Ig) is a lifesaving medicine derived from blood plasma. It is used to treat a large array of chronic diseases. It saves and improves the lives of hundreds of thousands people throughout Europe. Given the increase in demand and the lack of plasma collection, it is currently not possible to meet patients’ real immunoglobulin needs.

Plasma journey,
from donor to patient

Collecting a sufficient volume of plasma is key to meet patient needs. More than 5 million liters are actually lacking in EU.

Plasma donors

Amazing people give their plasma to save and improve lives of millions of people worldwilde.

Plasma is tested, frozen and stored

Plasma is sent to the fractionator

The fractionator is an industrial actor who extracts and secures proteins from plasma to manufacture medicines.

Each medicine is separated out

Immunoglobulin, albumin, coagulation factors and other essential proteins are separated out and processed.

Viral deactivation and purification

Pathogens inactivation and safety processes are essential and strictly monitored.

Inspection and packaging

Final medicine is inspected, tested and
packaged for use.

Distribution

Treatments make their way to hospitals and clinics.

Saving lives

Patients receive their plasma medicine at home or/and in hospital.
As an example, to treat one patient with CIDP 360 plasma donations per year are needed.

Plasma’s journey from donor to patient takes 7 to 12 months.

That’s why collecting enough plasma is vital

This long, specific and donor-based journey makes plasma derived medicinal products fabrication incomparable to any other medicine manufacturing process.

Hence the importance to always have a sufficient volume of plasma at all times. Your contribution with plasma donation is the only way to ensure patients get the treatment they need, without interruptions.

Want to know more about plasma donations?

Check out our donation process breakdown.

Plasma journey

FROM DONOR TO PATIENT

Plasma derived therapies

Immunoglobulin (Ig) is a lifesaving medicine derived from blood plasma. It is used to treat a large array of chronic diseases. It saves and improves the lives of hundreds of thousands people throughout Europe. Given the increase in demand and the lack of plasma collection, it is currently not possible to meet patients’ real immunoglobulin needs.

Plasma journey,
from donor to patient

Collecting a sufficient volume of plasma is key to meet patient needs. More than 5 million liters are actually lacking in EU.

Plasma donors

Amazing people give their plasma to save and improve lives of millions of people worldwilde.

Plasma is tested, frozen and stored

Plasma is sent to the fractionator

The fractionator is an industrial actor who extracts and secures proteins from plasma to manufacture medicines.

Each medicine is separated out

Immunoglobulin, albumin, coagulation factors and other essential proteins are separated out and processed.

Viral deactivation and purification

Pathogens inactivation and safety processes are essential and strictly monitored.

Inspection and packaging

Final medicine is inspected, tested and packaged for use.

Distribution

Treatments make their way to hospitals and clinics.

Saving lives

Patients receive their plasma medicine at home or/and in hospital.
As an example, to treat one patient with CIDP 360 plasma donations per year are needed.

Plasma’s journey from donor to patient takes 7 to 12 months.

That’s why collecting enough plasma is vital

This long, specific and donor-based journey makes plasma derived medicinal products fabrication incomparable to any other medicine manufacturing process.

Hence the importance to always have a sufficient volume of plasma at all times. Your contribution with plasma donation is the only way to ensure patients get the treatment they need, without interruptions.

Want to know more about plasma donations?

Check out our donation process breakdown.

Plasma journey

FROM DONOR TO PATIENT

Plasma derived therapies

Immunoglobulin (Ig) is a lifesaving medicine derived from blood plasma. It is used to treat a large array of chronic diseases. It saves and improves the lives of hundreds of thousands people throughout Europe. Given the increase in demand and the lack of plasma collection, it is currently not possible to meet patients’ real immunoglobulin needs.

Plasma journey,
from donor to patient

Collecting a sufficient volume of plasma is key to meet patient needs. More than 5 million liters are actually lacking in EU.

Plasma donors

Amazing people give their plasma to save and improve lives of millions of people worldwide.

Plasma is tested, frozen and stored

Plasma is sent to the fractionator

The fractionator is an industrial actor who extracts and secures proteins from plasma to manufacture medicines.

Each medicine is separated out

Immunoglobulin, albumin, coagulation factors and other essential proteins are separated out and processed.

Viral deactivation and purification

Pathogens inactivation and safety processes are essential and strictly monitored.

Inspection and packaging

Final medicine is inspected, tested and packaged for use.

Distribution

Treatments make their way to hospitals and clinics.

Saving lives

Patients receive their plasma medicine at home or/and in hospital. As an example, to treat one patient with CIDP 360 plasma donations per year are needed.

Plasma’s journey from donor to patient takes 7 to 12 months.

That’s why collecting enough plasma is vital

This long, specific and donor-based journey makes plasma derived medicinal products fabrication incomparable to any other medicine manufacturing process.

Hence the importance to always have a sufficient volume of plasma at all times.
Your contribution with plasma donation is the only way to ensure patients get the treatment they need, without interruptions.

Want to know more about plasma donations?

Check out our donation process breakdown.